Testosterone vaginal - Warner ChilcottAlternative Names: Testosterone IVR
Latest Information Update: 05 Dec 2007
At a glance
- Originator Warner Chilcott
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone congener stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Female sexual dysfunction
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 25 Jun 2004 Galen Holdings is now called Warner Chilcott
- 05 Jun 2002 Investigation in Female sexual dysfunction in USA (Vaginal)